163 related articles for article (PubMed ID: 37249621)
1. MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma.
Tang MCY; Ferreira TA; Marinkovic M; Jaarsma-Coes MG; Klaassen L; Vu THK; Creutzberg CL; Rodrigues MF; Horeweg N; Klaver YLB; Rasch CRN; Luyten GPM; Beenakker JM
Neuroradiology; 2023 Aug; 65(8):1271-1285. PubMed ID: 37249621
[TBL] [Abstract][Full Text] [Related]
2. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
4. Quantitative echography in primary uveal melanoma treated by proton beam therapy.
Mosci C; Lanza FB; Mosci S; Barla A
Can J Ophthalmol; 2014 Feb; 49(1):60-5. PubMed ID: 24513359
[TBL] [Abstract][Full Text] [Related]
5. Tumour Response in Uveal Melanomas Treated with Proton Beam Therapy.
Maschi C; Thariat J; Herault J; Caujolle JP
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):198-203. PubMed ID: 26385821
[TBL] [Abstract][Full Text] [Related]
6. The Economic Value of MR-Imaging for Uveal Melanoma.
Grech Fonk L; Ferreira TA; Webb AG; Luyten GPM; Beenakker JM
Clin Ophthalmol; 2020; 14():1135-1143. PubMed ID: 32425499
[TBL] [Abstract][Full Text] [Related]
7. MR imaging characteristics of uveal melanoma with histopathological validation.
Ferreira TA; Jaarsma-Coes MG; Marinkovic M; Verbist B; Verdijk RM; Jager MJ; Luyten GPM; Beenakker JM
Neuroradiology; 2022 Jan; 64(1):171-184. PubMed ID: 34718831
[TBL] [Abstract][Full Text] [Related]
8. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
Masoomian B; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
[TBL] [Abstract][Full Text] [Related]
9. Changes in ultrasound findings in posterior uveal melanoma after Ruthenium 106 brachytherapy.
Kaiserman I; Anteby I; Chowers I; Blumenthal EZ; Kliers I; Pe'er J
Ophthalmology; 2002 Jun; 109(6):1137-41. PubMed ID: 12045056
[TBL] [Abstract][Full Text] [Related]
10. Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis.
Thornton S; Coupland SE; Heimann H; Hussain R; Groenewald C; Kacperek A; Damato B; Taktak A; Eleuteri A; Kalirai H
Br J Ophthalmol; 2020 Oct; 104(10):1462-1466. PubMed ID: 32024655
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging and ultrasound evaluation of choroidal melanomas after proton-beam therapy.
Russo A; Mariotti C; Longo A; Foti PV; Avitabile T; Uva MG; Franco LM; Bonfiglio V; Milone P; Ettorre GC; Ragusa M; Purrello M; Caltabiano R; Puzzo L; Reibaldi M
Radiol Med; 2015 Jul; 120(7):634-40. PubMed ID: 25650084
[TBL] [Abstract][Full Text] [Related]
12. Salvage proton beam therapy in local recurrent uveal melanoma.
Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning.
Beenakker JW; Ferreira TA; Soemarwoto KP; Genders SW; Teeuwisse WM; Webb AG; Luyten GP
MAGMA; 2016 Jun; 29(3):571-7. PubMed ID: 26915081
[TBL] [Abstract][Full Text] [Related]
14. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
[TBL] [Abstract][Full Text] [Related]
15. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Magnetic Resonance Imaging-Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma.
Jaarsma-Coes MG; Ferreira TA; Marinkovic M; Vu THK; van Vught L; van Haren GR; Rodrigues MF; Klaver YLB; Verbist BM; Luyten GPM; Rasch CRN; Beenakker JM
Ophthalmol Retina; 2023 Feb; 7(2):178-188. PubMed ID: 35840053
[TBL] [Abstract][Full Text] [Related]
18. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
Verma V; Mehta MP
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning.
Lu JE; Welch RJ; Mishra KK; Daftari IK; Park SS
Eye (Lond); 2019 Dec; 33(12):1904-1910. PubMed ID: 31278380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
